Skip to content
Riskpilot
← Back to search
Sign in
Get full access
FORWARD PHARMA A/S
A/S
In liquidation
Advertising protection
CVR 28865880
Strandvejen 125, 2900
Hellerup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2005 · 20 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
FORWARD PHARMA A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-2M
-3M
-5M
-7M
-8M
2020
-11M
2021
-12M
2022
-6M
2023
-9M
2024
EBITDA
DKK millions
0M
-14M
-28M
-41M
-55M
-24M
2020
-25M
-4%
2021
-44M
-76%
2022
-8M
+82%
2023
-11M
-37%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-7.764
-10.813
-11.632
-6.131
-9.458
Staff expenses
-5.055
-2.877
-3.074
-1.827
-1.838
EBITDA
-24.321
-24.879
-43.890
-7.958
-11.296
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-24.321
-24.879
-43.890
-7.958
-11.296
Net financials
-17.882
12.608
12.407
4.125
1.364
Profit before tax
-42.203
-12.271
-31.483
-3.833
-9.932
Tax
-1
-0
-0
-0
-85.859
Net profit
-42.202
-12.271
-31.483
-3.833
75.928
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
574.866
561.060
529.878
704.685
835.352
Equity
474.107
461.863
430.397
426.446
488.330
Long-term debt
0
0
0
0
0
Short-term debt
100.759
99.197
99.482
278.239
347.022
Total debt
100.759
99.197
99.482
278.239
347.022
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1129603600.0%
This company
2020
2024
Equity ratio
58.5%
This company
38.2%
Market median
+53% vs market
2020
2024
Return on equity
15.5%
This company
18.4%
Market median
+16% vs market
2020
2024
Net profit margin (of gross profit)
7592764500.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.01×
This company
2020
2024
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on FORWARD PHARMA A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
